1. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study. Issue 5 (May 2023) Authors: Menzies-Gow, Andrew; Wechsler, Michael E; Brightling, Christopher E; Korn, Stephanie; Corren, Jonathan; Israel, Elliot; Chupp, Geoffrey; Bednarczyk, Artur; Ponnarambil, Sandhia; Caveney, Scott; Almqvist, Gun; Gołąbek, Monika; Simonsson, Linda; Lawson, Kaitlyn; Bowen, Karin; Colice, Gene; Hetzel, ... Journal: Lancet Issue: Volume 11:Issue 5(2023) Page Start: 425 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma. Issue 2 (31st January 2019) Authors: Busse, William W.; Brusselle, Guy G.; Korn, Stephanie; Kuna, Piotr; Magnan, Antoine; Cohen, David; Bowen, Karin; Piechowiak, Teresa; Wang, Millie M.; Colice, Gene Journal: European respiratory journal Issue: Volume 53:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials. Issue 7 (July 2018) Authors: Panettieri, Reynold A; Sjöbring, Ulf; Péterffy, AnnaMaria; Wessman, Peter; Bowen, Karin; Piper, Edward; Colice, Gene; Brightling, Christopher E Journal: Lancet Issue: Volume 6:Issue 7(2018) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development program. (14th March 2018) Authors: Panettieri Jr, Reynold A; Wang, Millie; Braddock, Martin; Bowen, Karin; Colice, Gene Journal: Immunotherapy Issue: Volume 10:Number 6(2018) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tralokinumab for the treatment of severe, uncontrolled asthma: the ATMOSPHERE clinical development program. (14th March 2018) Authors: Panettieri Jr, Reynold A; Wang, Millie; Braddock, Martin; Bowen, Karin; Colice, Gene Journal: Immunotherapy Issue: Volume 10:Number 6(2018) Page Start: 473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗